A CARE (Community, Academic, Research, Education) Needs Assessment was recently conducted on current treatment protocols and views of Canadian specialists surrounding the treatment of mCRPC. This program was directed at Canadian medical oncology, radiation oncology, and urology specialists involved in identifying, referring, treating and management of mCRPC. CARE Faculty members, Drs. Kim Chi (BCCA), Sebastien Hotte (Juravinski Cancer Centre), Brita Danielson (University of Alberta) and Alan So (BCCA), are leading specialists in medical oncology, radiation oncology, and urology, respectively. They have endorsed this initiative and validated the questionnaire content before it was distributed to their peers. The following combined analysis provides a composite of results and insights on the topic of mCRPC. The commentary in this analysis is provided by Drs. Kim Chi and Sebastien Hotte, and is geared towards medical oncologists.